Literature DB >> 19903285

A new strategy to improve the cost-effectiveness of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis testing of blood donations in sub-Saharan Africa: a pilot study in Burkina Faso.

Dramane Kania1, Lassana Sangaré, Jean Sakandé, Abdoulaye Koanda, Yacouba Kompingnin Nébié, Oumarou Zerbo, Alain Wilfried Combasséré, Innocent Pierre Guissou, François Rouet.   

Abstract

BACKGROUND: In Africa where blood-borne agents are highly prevalent, cheaper and feasible alternative strategies for blood donations testing are specifically required. STUDY DESIGN AND METHODS: From May to August 2002, 500 blood donations from Burkina Faso were tested for hepatitis B surface antigen (HBsAg), human immunodeficiency virus (HIV), syphilis, and hepatitis C virus (HCV) according to two distinct strategies. The first strategy was a conventional simultaneous screening of these four blood-borne infectious agents on each blood donation by using single-marker assays. The second strategy was a sequential screening starting by HBsAg. HBsAg-nonreactive blood donations were then further tested for HIV. If nonreactive, they were further tested for syphilis. If nonreactive, they were finally assessed for HCV antibodies. The accuracy and cost-effectiveness of the two strategies were compared.
RESULTS: By using the simultaneous strategy, the seroprevalences of HBsAg, HIV, syphilis, and HCV among blood donors in Ouagadougou were estimated to be 19.2, 9.8, 1.6, and 5.2%. No significant difference of HIV, syphilis, and HCV prevalence rates was observed by using the sequential strategy (9.2, 1.9, and 4.7%, respectively). Whatever the strategy used, 157 blood donations (31.4%) were found to be reactive for at least one transfusion-transmissible agent and were thus discarded. The sequential strategy allowed a cost decrease of euro 908.6, compared to the simultaneous strategy. Given that approximately there are 50,000 blood donations annually in Burkina Faso, the money savings reached potentially euro 90,860.
CONCLUSIONS: In resource-limited settings, the implementation of a sequential strategy appears as a pragmatic solution to promote safe blood supply and ensure sustainability of the system.

Entities:  

Mesh:

Year:  2009        PMID: 19903285     DOI: 10.1111/j.1537-2995.2009.02276.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  8 in total

1.  Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis among blood donors in Koudougou (Burkina Faso) in 2009.

Authors:  Marius Bolni Nagalo; Mahamoudou Sanou; Cyrille Bisseye; Marilène Inès Kaboré; Yacouba K Nebie; Kisito Kienou; Alice Kiba; Honorine Dahourou; Siaka Ouattara; Jean Didier Zongo; Jacques Simporé
Journal:  Blood Transfus       Date:  2011-07-18       Impact factor: 3.443

2.  The impact of external donor support through the U.S. President's Emergency Plan for AIDS Relief on the cost of red cell concentrate in Namibia, 2004-2011.

Authors:  John P Pitman; Adele Bocking; Robert Wilkinson; Maarten J Postma; Sridhar V Basavaraju; Bjorn von Finckenstein; Mary Mataranyika; Anthony A Marfin; David W Lowrance; Cees Th Smit Sibinga
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

3.  Seroprevalence of transfusion-transmissible infections and evaluation of the pre-donation screening performance at the Provincial Hospital of Tete, Mozambique.

Authors:  Jocelijn Stokx; Philippe Gillet; Anja De Weggheleire; Esther C Casas; Rosa Maendaenda; Adelino J Beulane; Ilhes V Jani; Solon Kidane; Carla D Mosse; Jan Jacobs; Emmanuel Bottieau
Journal:  BMC Infect Dis       Date:  2011-05-23       Impact factor: 3.090

4.  Epidemiology of syphilis in regional blood transfusion centres in Burkina Faso, West Africa.

Authors:  Cyrille Bisseye; Mahamoudou Sanou; Bolni Marius Nagalo; Alice Kiba; Tegwindé Rebeca Compaoré; Issoufou Tao; Jacques Simpore
Journal:  Pan Afr Med J       Date:  2013-10-28

5.  Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries.

Authors:  Azumi Ishizaki; Julie Bouscaillou; Niklas Luhmann; Stephanie Liu; Raissa Chua; Nick Walsh; Sarah Hess; Elena Ivanova; Teri Roberts; Philippa Easterbrook
Journal:  BMC Infect Dis       Date:  2017-11-01       Impact factor: 3.090

Review 6.  Residual risk of HIV, HCV, and HBV transmission by blood transfusion between 2015 and 2017 at the Regional Blood Transfusion Center of Ouagadougou, Burkina Faso.

Authors:  Arzouma Paul Yooda; Salam Sawadogo; Serge Théophile Soubeiga; Dorcas Obiri-Yeboah; Koumpingnin Nebie; Abdoul Karim Ouattara; Birama Diarra; Abibou Simpore; Yetema Dieudonné Yonli; Abdoul-Guaniyi Sawadogo; Bia Emile Drabo; Seimbou Zalla; Anita Pierrette Siritié; Rodrigue Sosthène Nana; Honorine Dahourou; Jacques Simpore
Journal:  J Blood Med       Date:  2019-02-01

7.  Economic analysis of three interventions of different intensity in improving school implementation of a government healthy canteen policy in Australia: costs, incremental and relative cost effectiveness.

Authors:  Kathryn L Reilly; Penny Reeves; Simon Deeming; Sze Lin Yoong; Luke Wolfenden; Nicole Nathan; John Wiggers
Journal:  BMC Public Health       Date:  2018-03-20       Impact factor: 3.295

8.  High prevalence of hepatitis B infections in Burkina Faso (1996-2017): a systematic review with meta-analysis of epidemiological studies.

Authors:  Moussa Lingani; Tomoyuki Akita; Serge Ouoba; Armel Moumini Sanou; Aya Sugiyama; Zekiba Tarnagda; Masayuki Ohisa; Halidou Tinto; Shunji Mishiro; Junko Tanaka
Journal:  BMC Public Health       Date:  2018-04-25       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.